{"transactions":[{"id":732665,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy","published_at":"2026-06-18T23:24:00.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) 25% vested upon the date of grant; (ii) 25% will vest on June 30, 2026, (iii) 25% will vest on September 30, 2026, and (iv) 25% will vest on December 31, 2026, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.7,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-029427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000149315226029427/ownership.xml","form_type":"4"}},{"id":1156523,"issuer":{"id":7732,"kind":"organization","name":"Fabric.AI, Inc."},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy","published_at":"2025-05-07T22:11:47.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested fully on the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.476,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001641172-25-009100","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1086745/000164117225009100/ownership.xml","form_type":"4"}},{"id":3946464,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2018-05-04T17:00:27.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":0.98,"exercise_date":"2018-05-02","expiration_date":"2023-05-02","underlying":"common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-18-006282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218006282/form4.xml","form_type":"4"}},{"id":4356571,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-07T12:50:33.000Z","date":"2017-04-06","kind":"purchase","acquired":true,"shares":13000,"price":0.336,"value":4368.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.335 to $0.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":418153,"source":{"system":"sec-edgar","filing":"0001559647-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/737207/000155964717000002/primary_doc.xml","form_type":"4"}},{"id":4356570,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-07T12:50:33.000Z","date":"2017-04-07","kind":"purchase","acquired":true,"shares":22500,"price":0.425,"value":9562.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.38 to $0.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":440653,"source":{"system":"sec-edgar","filing":"0001559647-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000155964717000002/primary_doc.xml","form_type":"4"}},{"id":4359419,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-05T17:41:28.000Z","date":"2017-04-05","kind":"purchase","acquired":true,"shares":97550,"price":0.312,"value":30435.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.29 to $0.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":405153,"source":{"system":"sec-edgar","filing":"0001559647-17-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000155964717000001/primary_doc.xml","form_type":"4"}},{"id":4470393,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-03T12:46:12.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares of common stock awarded to the reporting person on February 2, 2017 pursuant to the employment letter dated February 2, 2017 between the reporting person and the issuer. Such restricted shares shall vest upon the first execution and delivery by the issuer following the date of the employment letter of a definitive agreement involving the licensing by the issuer its Smarticles-based liposomal delivery technology. The restricted shares were issued under the issuer's 2014 Long-Term Incentive Plan."}],"balance_after":307603,"source":{"system":"sec-edgar","filing":"0001493152-17-001082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315217001082/form4.xml","form_type":"4"}},{"id":4506171,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2017-01-04T18:29:12.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2017, and options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2018."}],"balance_after":81000,"derivative":{"exercise_price":0.17,"expiration_date":"2022-01-03","underlying":"common stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001493152-17-000150","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315217000150/form4.xml","form_type":"4"}},{"id":4552110,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":36960,"kind":"person","name":"Ramelli Joseph W.","position":1,"cik":"0001559647","reported_name":"Ramelli Joseph W.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Options to purchase common stock","published_at":"2016-11-17T17:30:05.000Z","date":"2016-11-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":0.1,"exercise_date":"2016-11-15","expiration_date":"2021-11-15","underlying":"Common stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-16-015241","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315216015241/form4.xml","form_type":"4"}}]}